Loading your page…

Pharmaceutical group

Extrovis

13 medicines5 countries

A group of 4 companies with 13 medicines in 5 countries.

Its medicines

Group structure

4 companies in 2 countries

Hungary2

United States1

ExtrovisAuthorisation holder · 6 medicines

Headquarters not stated1

Extrovis EU LtdAuthorisation holder · 4 medicines · listed in the EU (EMA), Italy

Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.

Medicines

Every medicine of every company in the group, current ones first.

13 medicines

Medicine	Substance	Country	Status	Authorised
CARAC0.5% · Cream	Fluorouracil	United States	Marketed	2000
EFUDEX2% \| 5% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons · Solution	Fluorouracil	United States	Marketed	1970
EFUDEX5% · Cream	Fluorouracil	United States	Marketed	1970
FLUDARABINE PHOSPHATE50MG/2ML (25MG/ML) \| 50MG/2ML (25MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons \| 50MG/VIAL · Injectable	Fludarabine	United States	Marketed	2003
LACOSAMIDA ADROIQ 10 MG/ML SOLUCION PARA PERFUSION10 mg/ml · Solución para perfusión	Lacosamide	Spain	Marketed	2023
Lacosamide Adroiq	Lacosamide	EU (EMA)	Authorised	2023
LACOSAMIDE ADROIQSoluzione per infusione	Lacosamide	Italy	Authorised
Lacosamide Adroiq 10 mg/ml oplossing voor infusieOplossing voor infusie	Lacosamide	Netherlands	Authorised	2023
PEG 3350 AND ELECTROLYTES3350 236gm/bot; 2.97gm/bot; 6.74gm/bot; 5.86gm/bot; 22.74gm/bot \| 3350 240gm/bot; 2.98gm/bot; 6.72gm/bot; 5.84gm/bot; 22.72gm/bot · For solution	Macrogol, Potassium chloride, Bicarbonate, Sodium chloride, Sodium sulfate anhydrous	United States	Marketed	2009
SODIUM ACETATE100meq/50ml (2meq/ml) \| 200meq/100ml (2meq/ml) \| 400meq/100ml (4meq/ml) \| 40meq/20ml (2meq/ml) · Solution	Sodium acetate	United States	Marketed	1983
Sugammadex Adroiq	Sugammadex	EU (EMA)	Authorised	2023
SUGAMMADEX ADROIQSoluzione iniettabile	Sugammadex	Italy	Authorised
Sugammadex Adroiq 100 mg/ml oplossing voor injectieOplossing voor injectie	Sugammadex	Netherlands	Authorised	2023

Know your medicines, with the sources.

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

Join Prognia free

Countries

Where it holds or makes medicines, with how many are current.

Country	Medicines	Current	Companies
United States	6	6	Companies All medicines
European Union (EMA)	2	2	Companies All medicines
Italy	2	2	Companies All medicines
Netherlands	2	2	Companies All medicines
Spain	1	1	Companies All medicines

Also in the registers of France

Sources and licences

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.

European Medicines Agency

Source: European Medicines Agency (EPAR data).

Licence: EMA reuse policy (source acknowledgement required)

Agencia Española de Medicamentos y Productos Sanitarios (CIMA)

Fuente de la información: AEMPS (CIMA).

Licence: AEMPS open data reuse with attribution

U.S. Food and Drug Administration (Drugs@FDA, openFDA)

Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.

Licence: Public domain (U.S. Government work)

Base de données publique des médicaments (ANSM, HAS, UNCAM)

Source: BDPM (ANSM, HAS, UNCAM).

Licence: Licence Ouverte v1.0

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

All 9 sources

BDPM / ANSM, HAS and UNCAM

BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained

Licence: BDPM exact Licence Ouverte v1.0 (October 2011)

Agenzia Italiana del Farmaco (AIFA), Italy

Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.

Licence: CC BY 4.0; AIFA published open-data catalog

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim

Report an error or request removalCorrections from the company itself are welcome.

Extrovis

Group structure

Hungary2

United States1

Headquarters not stated1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Other big groups

Group structure

🇭🇺Hungary2

🇺🇸United States1

Headquarters not stated1

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Hungary2

United States1